NZD 0.02
(-4.76%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -1.45 Million NZD | 25.96% |
2022 | -1.82 Million NZD | -0.63% |
2021 | -2.05 Million NZD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 FY | - NZD | 25.96% |
2022 FY | - NZD | -0.63% |
2021 FY | - NZD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
AFT Pharmaceuticals Limited | 25.72 Million NZD | 105.647% |
Rua Bioscience Limited | -13.3 Million NZD | 89.082% |